About this trial
The goal of this observational study is to investigate cellular heterogeneity and inflammatory microenvironment features in gingival tissues from patients with aggressive periodontitis compared to chronic periodontitis and healthy controls, using single-cell and spatial transcriptomics combined with whole-genome sequencing.
The main question(s) it aims to answer are:
What are the differences in cellular composition, mesenchymal stem cell subpopulations, and gene expression profiles between aggressive periodontitis, chronic periodontitis, and healthy gingival tissues? Which key molecular markers, signaling pathways, and spatially resolved microenvironment patterns distinguish aggressive periodontitis from the more common chronic form? Are there disease-specific genetic variants associated with aggressive periodontitis identified through whole-genome sequencing of peripheral blood DNA?
Participants (already scheduled for tooth extraction or periodontal surgery as part of routine clinical care) will undergo:
Standard clinical periodontal examination and CBCT imaging Collection of a small gingival tissue sample (\~1×3×1 mm) during the planned extraction/surgery under local anesthesia Collection of 5 mL peripheral blood for DNA extraction No additional intervention, treatment, or follow-up visit is required beyond routine dental care.
Last updated: December 23, 2025
Eligibility criteria
Qualifiers
Aged 20-35 years
Radiographic evidence of at least 30% vertical bone loss at ≥2 tooth sites
Can be classified as Stage III/IV, Grade C periodontitis according to the 2018 new classification of periodontitis
With or without family history of periodontitis
Disqualifiers
Use of antibiotics within the past 3 months
Smoking >10 cigarettes per day
Uncontrolled severe diabetes (HbA1c level ≥6.7%)
Planning pregnancy, currently pregnant, or breastfeeding
Trial design
Treatments tested in this trial
- Not listed